THE EFFECT OF PEPTIDE IMMUNOTHERAPY ON FREQUENCY, MEMORY PHENOTYPE, CHEMOKINE RECEPTOR EXPRESSION AND MARKERS OF REGULATORY T CELL FUNCTION ALLERGAN-SPECIFIC T CELLS. A RANDOMIZED PROSPECTIVE CLINICAL TRIAL OF FEL D 1 PEPTIDE IMMUNOTHERAPY
- Registry ID
- U19-MMU-02
- Source registry
- HEALTH_CANADA
- Status
- Closed
- Study type
- INTERVENTIONAL
- Sponsor
- NATIONAL INSTITUTE OF HEALTH
- Start date
- 2014-12-16
- Completion date
- 2020-03-16
- Last update
- 2014-11-13
Conditions
Related clinical trials
- A SINGLE-CENTRE, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO INVESTIGATE THE RELATIVE EFFICACY AND SAFETY OF IMMUNOTHERAPY WITH SUBLIVAC FIX PHLEUM PROTENSE COMPARED TO PLACEBO IN GRASS POLLEN-ALLERGIC-PATIENTS WITH IGE-MEDIATED SEASONAL ALLERGIC RHINOCONJUNCTIVITIS."
- A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, ESCALATING, MULTIPLE DOSE STUDY IN BIRCH-ALLERGIC SUBJECTS TO ASSESS THE ASFETY, TOLERABILITY AND PHARMACODYNAMIC EFFECTS OF INTRADERMAL ADMINISTRATION OF BIRCH-SPIRE
- A MULTI-CENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PARALLEL-GROUP STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF GRASS-SPIRE IN SUBJECTS WITH ASTHMA AND GRASS-INDUCED RHINOCONJUNCTIVITIS
- A SINGLE GROUP STUDY EVALUATING REPRODUCIBILITY OF RHINITIS SYMPTOMS INDUCED BY ALLERGEN EXPOSURE IN THE RED MAPLE TRIALS ALLERGEN CHALLENGE THEATRE (ACT) IN SUBJECTS WITH GRASS POLLEN ALLERGY
- "AN OPTIONAL FOLLOW-UP STUDY TO EVALUATE THE CONTINUED EFFICACY OF TOLERMUNE HDM IN HOUSE DUST MITE ALLERGIC SUBJECTS FOLLOWING CHALLENGE WITH HOUSE DUST MITE ALLERGEN IN AN ENVIRONMENT EXPOSURE CHAMBER."
View on source registry